Evaluation of New Method for Measuring Stool Consistency

November 7, 2017 updated by: Yakult Honsha European Research Center, ESV

Evaluation of a New Method for Measuring Stool Consistency, Using a Texture Analyser (TA.XT Express Texture Analyser)

This study is designed to validate a new direct method for the measurement of stool consistency, using Texture Analyser. Forty healthy subjects are enrolled in this trial for collection of stool samples. Every stool produced during 2 collection periods of approximately 60 hours each is collected and subjected to the measurement of consistency using Texture Analyser. The stool consistency results are compared with the Bristol Stool Form Scale scores for each stool. The relationships of stool consistency with other stool parameters, bowel habit and sleeping habit are also evaluated.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

It is now obvious that the proper functioning of the gastrointestinal tract has a positive effect on the quality of life. Normal bowel habits vary considerably from person to person with regard to frequency of bowel movements, and bulk and consistency of stools. Constipation is the common digestive complaint in European populations, and softening stool consistency can be regarded as beneficial for such population in terms of reducing incidence of hard or lumpy stools .

The Bristol Stool Form Scale (BS) is validated as a surrogate measure for gastrointestinal transit time, and has been also applied to an evaluation of stool consistency. Subjects compare their stool with the BS chart consisting of seven categories and choose one score which has a nearest analog form. The BS has been widely used in the studies to evaluate changes in stool consistency after dietary intervention using probiotics and/or prebiotics. However, there is a lack of evidence in the validity of BS to yield consistent and reproducible estimates of changes in stool consistency over time. In order to obtain a closer estimate of its change, it would be preferred to use a more directly observable and objective parameter or combination of parameters.

From the above mentioned backgrounds, this study is conducted to validate a new direct method for the measurement of stool consistency, using Texture Analyser: TA.XTExpress Texture Analyser (Stable Micro Systems Ltd.).

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Aalst, Belgium, 9300
        • Onze-Lieve-Vrouw Hospital Aalst

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Informed consent obtained before any study-related activities.
  • Healthy female or male aged 18 years (inclusive) or older.
  • Is willing and able to provide at least 3 stool samples during 2 collection periods of approximately 60 hours, to store the samples in appropriate conditions and to return the samples within the required timeframe.
  • Is willing and able to complete a diary during the stool collection periods in order to collect information about form of the stools (based on the Bristol Stool Form Scale classification), bowel habit and sleep habit.
  • Understands the Dutch or English language (reading, writing, speaking).

Exclusion Criteria:

  • Language barrier, mental or legal incapacity, unwillingness or inability to understand or not being able to participate in this trial.
  • Is treated (i.e., currently treated, treated within 1 month before inclusion) for constipation, diarrhoea or any other illness, by use of antibiotics or any other treatment with impact on defecation.
  • Females of child bearing potential who are pregnant, breast-feeding or intend to become pregnant.
  • Is unable to refrain from or anticipates the use of disallowed medications, e.g., antibiotics, laxatives, anti-diarrheal medication.
  • Has any history of drug and/or alcohol abuse.
  • Any clinically significant disease which in the Investigator's opinion could interfere with the safety of study participants or with the results of the study.
  • Participation in another interventional clinical study or receipt of any investigational product within 1 month before visit 1.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: OTHER
  • Allocation: NA
  • Interventional Model: SINGLE_GROUP
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
OTHER: Specimen collection
Collection of stool samples
The subjects collect stool samples to be used for validation of a new direct measurement of stool consistency. Every stool sample produced during 2 collection periods of approximately 60 hours each have to be collected using the Commode Specimen Collection System (Medline Industries, Inc.). Each collection period starts preferably in the evening (20h00) and ends 3 days later in the morning (08h00). The collected samples must be stored at subject's home in a refrigerator provided by the sponsor until handover to the site staff.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Stool consistency
Time Frame: Two stool collection periods of approximately 60 hours each
Stool consistency is measured as force (g) during compression by Texture Analyser. A cylinder probe is put vertically into the object with a constant speed and the force is measured when reaching down to the target (5 mm down from the surface) as an outcome.
Two stool collection periods of approximately 60 hours each

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Bristol Stool Form Scale score
Time Frame: Two stool collection periods of approximately 60 hours each
Bristol Stool Form Scale (BS) is for classifying the form of stool into 7 categories scored from 1 to 7; (1) Separate hard lumps like nuts (difficult to pass); (2) Sausage-shaped but lumpy; (3) Like a sausage but with cracks on its surface; (4) Like a sausage or snake, smooth and soft; (5) Soft blobs with clear-cut edges (passed easily); (6) Fluffy pieces with ragged edges, a mushy stool; (7) Watery, no solid pieces, entirely liquid. Subjects choose one of the BS scores which has a nearest analog form with their stools at every defecation.
Two stool collection periods of approximately 60 hours each
Stool water content
Time Frame: Two stool collection periods of approximately 60 hours each
Percentage of water in stool (weight/weight %)
Two stool collection periods of approximately 60 hours each
Stool mucin
Time Frame: Two stool collection periods of approximately 60 hours each
Concentration of mucin in stool
Two stool collection periods of approximately 60 hours each
Stool pH
Time Frame: Two stool collection periods of approximately 60 hours each
Degree of stool pH
Two stool collection periods of approximately 60 hours each
Stool metabolites
Time Frame: Two stool collection periods of approximately 60 hours each
Concentrations of stool metabolites including organic acids
Two stool collection periods of approximately 60 hours each
Stool microbiota composition
Time Frame: Two stool collection periods of approximately 60 hours each
Relative abundance of microbiota species (% of total) in stool
Two stool collection periods of approximately 60 hours each
Stool amount
Time Frame: Two stool collection periods of approximately 60 hours each
Weight (g) of stool produced in each defecation
Two stool collection periods of approximately 60 hours each
Bowel habit
Time Frame: Two stool collection periods of approximately 60 hours each
Presence or absence of straining during evacuation, presence or absence of sensation of remaining stool in the rectum after evacuation
Two stool collection periods of approximately 60 hours each
Sleep habit
Time Frame: Two stool collection periods of approximately 60 hours each
Getting-up time, going-to-bed time and sleeping hours
Two stool collection periods of approximately 60 hours each

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ignace Demeyer, Dr., Onze-Lieve-Vrouw Hospital Aalst

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

June 2, 2017

Primary Completion (ACTUAL)

July 6, 2017

Study Completion (ACTUAL)

July 6, 2017

Study Registration Dates

First Submitted

June 8, 2017

First Submitted That Met QC Criteria

June 14, 2017

First Posted (ACTUAL)

June 15, 2017

Study Record Updates

Last Update Posted (ACTUAL)

November 9, 2017

Last Update Submitted That Met QC Criteria

November 7, 2017

Last Verified

November 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • YHER16-TAXT

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on Collection of stool samples

Subscribe